Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 3
2004 4
2005 2
2006 4
2007 4
2008 4
2009 3
2010 3
2011 2
2012 1
2013 5
2014 6
2015 10
2016 8
2017 11
2018 11
2019 2
2020 6
2021 13
2022 3
2023 5
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

98 results

Results by year

Filters applied: . Clear all
Page 1
Osimertinib.
Malapelle U, Ricciuti B, Baglivo S, Pepe F, Pisapia P, Anastasi P, Tazza M, Sidoni A, Liberati AM, Bellezza G, Chiari R, Metro G. Malapelle U, et al. Among authors: bellezza g. Recent Results Cancer Res. 2018;211:257-276. doi: 10.1007/978-3-319-91442-8_18. Recent Results Cancer Res. 2018. PMID: 30069773 Review.
Current Challenges for IDO2 as Target in Cancer Immunotherapy.
Mondanelli G, Mandarano M, Belladonna ML, Suvieri C, Pelliccia C, Bellezza G, Sidoni A, Carvalho A, Grohmann U, Volpi C. Mondanelli G, et al. Among authors: bellezza g. Front Immunol. 2021 Apr 21;12:679953. doi: 10.3389/fimmu.2021.679953. eCollection 2021. Front Immunol. 2021. PMID: 33968089 Free PMC article. Review.
Polyangiitis overlap syndrome: a rare clinical entity.
Bruno L, Mandarano M, Bellezza G, Sidoni A, Gerli R, Bartoloni E, Perricone C. Bruno L, et al. Among authors: bellezza g. Rheumatol Int. 2023 Mar;43(3):537-543. doi: 10.1007/s00296-023-05281-x. Epub 2023 Jan 31. Rheumatol Int. 2023. PMID: 36719484 Free PMC article. Review.
Future options for ALK-positive non-small cell lung cancer.
Iacono D, Chiari R, Metro G, Bennati C, Bellezza G, Cenci M, Ricciuti B, Sidoni A, Baglivo S, Minotti V, Crinò L. Iacono D, et al. Among authors: bellezza g. Lung Cancer. 2015 Mar;87(3):211-9. doi: 10.1016/j.lungcan.2014.12.017. Epub 2015 Jan 3. Lung Cancer. 2015. PMID: 25601484 Review.
Immune checkpoint inhibitors for unresectable malignant pleural mesothelioma.
Metro G, Signorelli D, Pizzutilo EG, Giannetta L, Cerea G, Garaffa M, Friedlaender A, Addeo A, Mandarano M, Bellezza G, Roila F. Metro G, et al. Among authors: bellezza g. Hum Vaccin Immunother. 2021 Sep 2;17(9):2972-2980. doi: 10.1080/21645515.2021.1917933. Epub 2021 May 18. Hum Vaccin Immunother. 2021. PMID: 34003722 Free PMC article.
Osimertinib in patients with advanced epidermal growth factor receptor T790M mutation-positive non-small cell lung cancer: rationale, evidence and place in therapy.
Ricciuti B, Baglivo S, Paglialunga L, De Giglio A, Bellezza G, Chiari R, Crinò L, Metro G. Ricciuti B, et al. Among authors: bellezza g. Ther Adv Med Oncol. 2017 Jun;9(6):387-404. doi: 10.1177/1758834017702820. Epub 2017 Apr 16. Ther Adv Med Oncol. 2017. PMID: 28607578 Free PMC article. Review.
Ectopic prostatic tissue in the bladder.
Bellezza G, Sidoni A, Cavaliere A. Bellezza G, et al. Int J Urol. 2005 Dec;12(12):1066-8. doi: 10.1111/j.1442-2042.2005.01210.x. Int J Urol. 2005. PMID: 16409614 Review.
98 results